- International Union Against Cancer. In: Sobin LH, Wittekind Ch, eds. TNM classification of malignant tumours, 5th edn. New York: Wiley-Liss; 1997.
- American Joint Committee on Cancer. In: Fleming ID, Cooper JS, Henson DE, et al., eds. AJCC cancer staging manual, 5th edn. Philadelphia, PA: LippincottRaven, 1997.
- Carbone A, Dolcetti R, Shaha AR, et al. What's new in the biology and treatment of undifferentiated carcinoma of nasopharyngeal type? Acta Otolaryngol 2001; 121: 884-95.
- DeNittis AS, Machtay M, Rosenthal DI, et al. Advanced oropharyngeal carcinoma treated with surgery and radiotherapy: oncologic outcome and functional assessment Am J Otolaryngol 2001 ; 22: 329-35.
- Stell PM. Management of malignant lymph nodes of the neck. In: Bull TR, Ransome J, Holden HB, eds. Recent advances in otolaryngology. Edinburgh: Churchill Livingstone, 1978: 125-39.
- Lindberg R. Distribution of cervical lymph node metastases from squamous cell carcinoma of the upper respiratory and digestive tracts. Cancer 1972; 29:14469.
- Stell PM, Dalby JE, Singh D, Taylor W. The fixed cervical lymph node. Cancer 1984; 53: 336-41.
- Stell PM. Fixed, bilateral cervical nodes. J Laryngol Otol 1983; 97: 851-6.
- Gavilán J. Controversial issues in the management of the N + neck. Proc 5th Int Conf Head Neck Cancer, San Francisco, CA, 2000: 443-8.
- Heppt W, Lenarz T, Gademann G, Fritz P, Guckel F, Born IA. Detection of muscle, vein and artery infiltrations of cervical lymphatic metastases. Laryngorhinootologie 1989; 68: 419-24(in German).
- Andersen PE. Surgical management of extensive cervical metastasis. Proc 5th Int Conf Head Neck Cancer, San Francisco, CA, 2000: 449-54.
- Myers EN, Pagan JJ. Treatment of the N+ neck in squamous cell carcinoma of the upper aerodigestive tract. Otolaryngol Clin North Am 1998; 31: 671-86.
- Donegan JO. Combined therapy for fixed cervical lymph nodes in head and neck cancer. Ear Nose Throat J 1987; 66: 95-8.
- Ferlito A, Shaha AR, Silver CE, Rinaldo A, Mondin V. Incidence and sites of distant metastases from head and neck cancer. ORL J Otorhinolaryngol Relat Spec 2001; 63: 202-6.
- Beitler JJ, Smith RV, Haynes H, et al. A phase I clinical trial of prolonged infusion of hydroxyurea in combination with hyperfractionated, accelerated, external radiation therapy in patients with advanced squamous cell cancer of the head and neck. Invest New Drugs 1998; 16: 161-9.
- Narayan K, Crane CH, Kleid S, Hughes PG, Peters LJ. Planned neck dissection as an adjunct to the management of patients with advanced neck disease treated with definitive radiotherapy: for some or for all? Head Neck 1999; 21: 606-13.
- Petruzzelli GJ, Emami B. Nonsurgical treatment of advanced metastatic cervical disease in cancer of the larynx. ORL J Otorhinolaryngol Relat Spec 2000; 62: 226-33.
- Kowalski LP. Strategies in the management of recurrent and inoperable cancer. Proc 5th Int Conf Head Neck Cancer, San Francisco, CA, 2000: 561-7.
- Smith RV, Beitler J, Edelman M, Silver C, Wadler S. Occult neck disease in patients treated with concomitant hydroxyurea and hyperfractionated radiation therapy. Paper presented at the New York Head and Neck Society, 24 March, 1999.
- Goodwin WJ Jr. Salvage surgery for patients with recurrent squamous cell carcinoma of the upper aerodigestive tract: when do the ends justify the means? Laryngoscope 2000; 110 (Suppl 93): 1-18.
Acta Oto-Laryngologica
Volume 122, 2002 - Issue 2